Quest Diagnostics EPS Beats Expectations

Quest Diagnostics EPS Beats Expectations

Source: 
Motley Fool
snippet: 
  • Quest Diagnostics reported revenues of $2.49 billion for Q3 2024, outperforming analyst expectations of $2.425 billion.
  • Adjusted diluted earnings per share (EPS) reached $2.30, also surpassing the estimated $2.26.
  • Adjusted operating income margins fell slightly from 16.6% to 15.5%, indicating cost pressure despite revenue growth.